Document is current

Any future updates will be listed below

Correction: Identification and validation of targets of swertiamarin on idiopathic pulmonary fibrosis through bioinformatics and molecular docking-based approach

Crossref DOI link: https://doi.org/10.1186/s12906-024-04616-w

Published Online: 2024-08-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark